Resveratrol inhibits LXRα-dependent hepatic lipogenesis through novel antioxidant Sestrin2 gene induction.
Toxicol Appl Pharmacol
; 271(1): 95-105, 2013 Aug 15.
Article
em En
| MEDLINE
| ID: mdl-23651738
Palavras-chave
ACC; AMP-activated protein kinase; AMPK; Acetyl-CoA carboxylase; DN-AMPK; Dominant-negative AMP-activated protein kinase; FAS; FXR; Farnesoid X receptor; Fatty acid synthase; GSH; HFD; Hepatic lipogenesis; High-fat diet; LXRE; LXRα; Liver X receptor elements; Liver X receptor- α; Liver X receptor-α; NAFLD; NASH; NF-E2-related factor 2; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Nrf2; PXR; ROS; RXR; Reactive oxygen species; Resveratrol; Retinoid X receptor; SCD-1; SREBP-1c; Sesn; Sestrin; Sirt1; Sirtuin 1; Stearoyl-CoA desaturase-1; Sterol regulatory element binding protein-1c; T090; T0901317; glutathione; pregnane X receptor
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Estilbenos
/
Proteínas
/
Receptores Nucleares Órfãos
/
Antioxidantes
Limite:
Animals
/
Humans
/
Male
Idioma:
En
Ano de publicação:
2013
Tipo de documento:
Article